These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8505149)

  • 1. CD4-binding compounds: an assay to detect new classes of immunopharmacological agents.
    Chandler G; Elcock C; Depledge P; Wrigley S; Mous J; Malkovsky M; Moore M; Gammon G
    Int J Immunopharmacol; 1993 Apr; 15(3):361-9. PubMed ID: 8505149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules.
    Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M
    Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120.
    Weaver JL; Gergely P; Pine PS; Patzer E; Aszalos A
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1125-30. PubMed ID: 1979910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S; Gulick R; Chess L
    J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
    Harrop HA; Coombe DR; Rider CC
    AIDS; 1994 Feb; 8(2):183-92. PubMed ID: 8043225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
    Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbent assay.
    Gilbert M; Brigido L; Müller WE; Hansen JE; Ezekowitz RA; Mills J
    J Virol Methods; 1993 Apr; 42(1):1-12. PubMed ID: 8100569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of T cell CD4 epitopes in HIV-infected individuals.
    Kunkl A; Valle MT; Fenoglio D; Dodi F; Morandi N; Rizzo F; Manca F
    Eur J Histochem; 1994; 38 Suppl 1():41-6. PubMed ID: 8547709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4.
    Attanasio R; Kanda P; Stunz GW; Buck DW; Kennedy RC
    Mol Immunol; 1993 Jan; 30(1):9-17. PubMed ID: 8417378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
    Moore JP
    AIDS; 1990 Apr; 4(4):297-305. PubMed ID: 2190604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunity against the CD4 receptor by using an antibody antigenized with residues 41-55 of the first extracellular domain.
    Lanza P; Billetta R; Antonenko S; Zanetti M
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11683-7. PubMed ID: 8265609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 changes conformation upon ligand binding.
    Szabò G; Pine PS; Weaver JL; Rao PE; Aszalos A
    J Immunol; 1992 Dec; 149(11):3596-604. PubMed ID: 1431129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic antibodies of a predefined specificity generated against CDR3VH synthetic peptides define a private anti-CD4 idiotype.
    Attanasio R; Kennedy RC; Allan JS; Maino VC; Buck D; Kanda P
    Mol Immunol; 1990 Jun; 27(6):513-22. PubMed ID: 2116595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.
    Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems.
    Sjölander S; Hansen JE; Lövgren-Bengtsson K; Akerblom L; Morein B
    Vaccine; 1996 Mar; 14(4):344-52. PubMed ID: 8744563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight.
    Cushman M; Wang PL; Chang SH; Wild C; De Clercq E; Schols D; Goldman ME; Bowen JA
    J Med Chem; 1991 Jan; 34(1):329-37. PubMed ID: 1704065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.